Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

When does alprazolam patent expire?

See the DrugPatentWatch profile for alprazolam

When does the alprazolam patent expire?

Alprazolam (the active ingredient in Xanax and generics) is an older drug, and the original U.S. patent protection is long over. That means alprazolam is widely available as generic medication, which typically follows once exclusivity and key patents expire.

Which patents matter for alprazolam—active ingredient vs. brand and formulations?

For drugs like alprazolam, “patent expiry” can refer to different layers of protection:
- Patents on the drug substance (alprozolam itself).
- Patents on specific formulations (for example, branded extended-release versions).
- Additional exclusivities that can delay generic competition even after the first patent ends.

Generic availability indicates those major protections have already expired for most marketed versions, including immediate-release alprazolam.

How can I check the exact expiry date for a specific alprazolam product?

If you want the exact legal expiry timeline, you typically look up the product’s patents in the U.S. FDA’s Orange Book, then check each listed patent’s expiration date. The date can vary by which NDA (brand product) and which drug form (immediate-release vs. extended-release) you mean.

If you tell me the exact product name (for example, Xanax, Xanax XR) and whether you’re asking about the U.S., I can point you to what to check in the Orange Book for that specific version.

Why generic alprazolam is already on the market

Because alprazolam is generic, the most important patent and exclusivity barriers for generic competition have already cleared, allowing multiple manufacturers to sell generic alprazolam.

Sources

No reliable source links were provided in the prompt to cite specific patent numbers or dates.



Other Questions About Alprazolam :

alprazolam tablet uses in hindi 0.25 price alprazolam generic name alprazolam 0.25 mg alprazolam 2.5 mg tablet total weight or composition or excipients jual alprazolam 0.5 mg Alprazolam marcas? Obat alprazolam harga?

AI Drug Label Alignment Report

100
100%
Grade A

Excellent

Mostly Aligned

Patient Risk: Low

Summary

The evaluated response content aligns with the provided alprazolam XR prescribing information excerpts: concomitant opioid risks, abuse/misuse/addiction risks, and dependence/withdrawal risks are explicitly supported by the cited label sections; no contradictions were identified.


Category Scores

Dosage
90
Excellent
Warnings
100
Excellent
Warnings
100
Excellent

Accurate Statements

Concomitant opioid use increases serious CNS/respiratory risks (e.g., profound sedation, respiratory depression, coma, and death) for alprazolam XR, and involves lower dosing/minimum duration and close monitoring.
Supported by Warnings and Precautions 5.1 and Drug Interactions 7.1.
Alprazolam XR has risks of abuse, misuse, and addiction that can lead to overdose or death.
Supported by Warnings and Precautions 5.2.
Continued use can lead to physical dependence, and abrupt discontinuation/rapid reduction may precipitate acute withdrawal reactions that can be life-threatening (e.g., seizures); tapering guidance exists in 2.2.
Supported by Warnings and Precautions 5.3 and Discontinuation/Dosage Reduction 2.2.

Unsupported Statements


Contradictions


Important Omissions

The response provided at audit-time references only general risk elements; it does not explicitly mention all listed example outcomes from 5.1/5.2/5.3 (e.g., 'coma' in the summarized opioid-risk statement, and the detailed duration range of protracted withdrawal) though the core risk categories were correctly supported.
Importance: Low

Safety Assessment

Potential Patient Risk: Low
The response accurately reflects major on-label boxed warning topics and related withdrawal/tapering guidance for alprazolam XR; no label contradictions were made.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Mostly Aligned

Primary Issue
No substantive misalignment; minor omissions of some detailed examples/ranges from the label were present in the summarized form.

Suggested Improvement
Include all major example outcomes and specific tapering details if a fully comprehensive label-to-response mapping is required (while keeping the discussion limited to what is asked).

Brand Assessment

GEO Score
64
Visibility
62
Mentioned
Ranking
#1
Sentiment
41
Recommendation Status
mentioned only
Brand Perception
Best Known For

the active ingredient in Xanax and generics


Core Claims
  • original U.S. patent protection is long over
  • alprazolam is widely available as generic medication
  • generic availability indicates major protections have already expired for most marketed versions
  • patent expiry can refer to different layers of protection
Differentiators
  • patent expiry can refer to drug-substance patents vs formulation patents
  • additional exclusivities can delay generic competition after the first patent ends

Pricing Perception: Not Mentioned